Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2014

Open Access 01-12-2014 | Research article

Effects of curcuminoids identified in rhizomes of Curcuma longa on BACE-1 inhibitory and behavioral activity and lifespan of Alzheimer’s disease Drosophila models

Authors: Xue Wang, Jun-Ran Kim, Seong-Baek Lee, Young-Joon Kim, Moon Young Jung, Hyung-Wook Kwon, Young-Joon Ahn

Published in: BMC Complementary Medicine and Therapies | Issue 1/2014

Login to get access

Abstract

Background

Alzheimer’s disease (AD) is the most common type of presenile and senile dementia. The human β-amyloid precursor cleavage enzyme (BACE-1) is a key enzyme responsible for amyloid plaque production, which implicates the progress and symptoms of AD. Here we assessed the anti-BACE-1 and behavioral activities of curcuminoids from rhizomes of Curcuma longa (Zingiberaceae), diarylalkyls curcumin (CCN), demethoxycurcumin (DMCCN), and bisdemethoxycurcumin (BDMCCN) against AD Drosophila melanogaster models.

Methods

Neuro-protective ability of the curcuminoids was assessed using Drosophila melanogaster model system overexpressing BACE-1 and its substrate APP in compound eyes and entire neurons. Feeding and climbing activity, lifespan, and morphostructural changes in fly eyes also were evaluated.

Results

BDMCCN has the strongest inhibitory activity toward BACE-1 with 17 μM IC50, which was 20 and 13 times lower than those of CCN and DMCCN respectively. Overexpression of APP/BACE-1 resulted in the progressive and measurable defects in morphology of eyes and locomotion. Remarkably, supplementing diet with either 1 mM BDMCCN or 1 mM CCN rescued APP/BACE1-expressing flies and kept them from developing both morphological and behavioral defects. Our results suggest that structural characteristics, such as degrees of saturation, types of carbon skeleton and functional group, and hydrophobicity appear to play a role in determining inhibitory potency of curcuminoids on BACE-1.

Conclusion

Further studies will warrant possible applications of curcuminoids as therapeutic BACE-1 blockers.
Appendix
Available only for authorised users
Literature
1.
Ferri C, Prince M, Brayne C, Brodaty H, Flatiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes P, Rimmer E, Scazufca M: Global prevalence of dementia: a Delphi consensus study. Lancet. 2005, 366: 2112-2117. 10.1016/S0140-6736(05)67889-0.CrossRefPubMedPubMedCentral
2.
Kalaria R, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P: Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008, 7: 812-826. 10.1016/S1474-4422(08)70169-8.CrossRefPubMedPubMedCentral
3.
Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM: Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007, 3: 186-191. 10.1016/j.jalz.2007.04.381.CrossRefPubMed
4.
Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002, 297: 353-356. 10.1126/science.1072994.CrossRefPubMed
5.
Suh YH, Checler F: Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer’s disease. Pharmacol Rev. 2002, 54: 469-525. 10.1124/pr.54.3.469.CrossRefPubMed
6.
Ghosh AK, Gemma S, Tang J: beta-Secretase as a therapeutic target for Alzheimer’s disease. Neurotherapeutics. 2008, 5: 399-408. 10.1016/j.nurt.2008.05.007.CrossRefPubMedPubMedCentral
7.
Mancini F, De Simone A, Andrisano V: Bata-secrtase as a target for Alzheimer’s disease drug discovery: an overview of in vitro methods for characterization of inhibitors. Anal Bioanal Chem. 2011, 400: 1979-1996. 10.1007/s00216-011-4963-x.CrossRefPubMed
8.
Greeve I, Kretzschmar D, Tschäpe JA, Beyn A, Brellinger C, Schweizer M, Nitsch RM, Reifegerste R: Age-dependent neurodegeneration and Alzheimer amyloid plaque formation in transgenic Drosophila. J Neurosci. 2004, 24: 3899-3906. 10.1523/JNEUROSCI.0283-04.2004.CrossRefPubMed
9.
Crowther DC, Kinghorn KJ, Miranda E, Page R, Curry JA, Duthie FA, Gubb DC, Lomas DA: Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s disease. Neuroscience. 2005, 132: 123-135. 10.1016/j.neuroscience.2004.12.025.CrossRefPubMed
10.
Chakraborty R, Vepuri V, Mhatre SD, Paddock BE, Miller S, Michelson SJ, Delvadia R, Desai A, Vinokur M, Melicharek DJ, Utreja S, Khandelwal P, Ansaloni S, Goldstein LE, Moir RD, Lee JC, Tabb LP, Saunders AJ, Marenda DR: Characterization of a Drosophila Alzheimer’s disease model: pharmacological rescue of cognitive defects. PLoS One. 2011, 6 (6): e20799-10.1371/journal.pone.0020799.CrossRefPubMedPubMedCentral
11.
Thompson LA, Bronson JJ, Zusi FC: Progress in the discovery of BACE inhibitors. Curr Pharm Des. 2005, 11: 3383-3404. 10.2174/138161205774370825.CrossRefPubMed
12.
John V: Human beta-secretase (BACE) and BACE inhibitors: progress report. Curr Top Med Chem. 2006, 6: 569-578. 10.2174/156802606776743084.CrossRefPubMed
13.
Erdogan Orhan I: Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer’s disease. Curr Med Chem. 2012, 19: 2252-2261.CrossRefPubMed
14.
15.
Raskin I, Ribnicky DM, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, Brinker A, Moreno DA, Ripoll C, Yakoby N, O’Neal JM, Cornwell T, Pastor I, Fridlender B: Plants and human health in the twenty-first century. Trends Biotechnol. 2002, 20: 522-531. 10.1016/S0167-7799(02)02080-2.CrossRefPubMed
16.
Mukherjee PK, Kumar V, Mal M, Houghton PJ: Acetylcholinesterase inhibitors from plants. Phytomedicine. 2007, 14: 289-300. 10.1016/j.phymed.2007.02.002.CrossRefPubMed
17.
Lee KS, Lee BS, Semnari S, Avanesian A, Um CY, Jeon HJ, Seong KM, Yu K, Min KJ, Jafari M: Curcumin extends life span, improves health span, and modulates the expression of age-associated aging genes in Drosophila melanogaster. Rejuvenation Res. 2010, 13: 561-570. 10.1089/rej.2010.1031.CrossRefPubMed
18.
Caesar I, Jonson M, Nilsson KPR, Thor S, Hammarström P: Curcumin promotes A-beta fibrillation and reduces neurotoxicity in transgenic Drosophila. PLoS One. 2012, 7 (2): e31424-10.1371/journal.pone.0031424.CrossRefPubMedPubMedCentral
19.
Tang E, Eisenbrand G: Chinese Drugs of Plant Origin. 1992, New York: SpringerCrossRef
20.
Araújo CC, Leon LL: Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz. 2001, 96: 723-728. 10.1590/S0074-02762001000500026.CrossRefPubMed
21.
Kuhn MA, Winston D: Herbal Therapy and Supplements: A Scientific & Traditional Approach. 2001, New York: Lippincott, 330-335.
22.
Jeon SY, Bae K, Seong YH, Song KS: Green tea catechins as a BACE1 (β-secretase) inhibitor. Bioorg Med Chem Lett. 2003, 13: 3905-3908. 10.1016/j.bmcl.2003.09.018.CrossRefPubMed
23.
Stachel SJ, Coburn CA, Steele TG, Jones KG, Loutzenhiser EF, Gregro AR: Structure-based design of potent and selective cell-permeable inhibitors of human β-secretase (BACE-1). J Med Chem. 2004, 47: 6447-6450. 10.1021/jm049379g.CrossRefPubMed
24.
Lv L, Yang QY, Zhao Y, Yao CS, Sun Y, Yang EJ, Song KS, Mook-Jung I, Fang WS: BACE1 (beta-secretase) inhibitory chromone glycosides from Aloe vera and Aloe nobilis. Planta Med. 2008, 74: 540-545. 10.1055/s-2008-1074496.CrossRefPubMed
25.
Perumalsamy H, Kim JR, Oh SM, Jung JW, Ahn YJ, Kwon HW: Novel histopathological and molecular effects of natural compound pellitorine on larval midgut epithelium and anal gills of Aedes aegypti. PLoS One. 2013, 8 (11): e80226-10.1371/journal.pone.0080226.CrossRefPubMedPubMedCentral
26.
Pirooznia SK, Sarthi J, Johnson AA, Toth MS, Chiu K, Koduri S, Elefant F: Tip60 HAT Activity Mediates APP Induced Lethality and Apoptotic Cell Death in the CNS of a Drosophila Alzheimer’s Disease Model. PLoS One. 2012, 7 (7): e41776-10.1371/journal.pone.0041776.CrossRefPubMedPubMedCentral
27.
Kwak YD, Wang R, Li JJ, Zhang YW, Xu H, Liao FF: Differential regulation of BACE1 expression by oxidative and nitrosative signals. Mol Neurodegener. 2011, 6: 17-10.1186/1750-1326-6-17.CrossRefPubMedPubMedCentral
28.
29.
Hartman H, Hayes TL: Scanning electron microscopy of Drosophila. J Hered. 1971, 62: 41-44.PubMed
30.
Park JH, Jung JW, Ahn YJ, Kwon HW: Neuroprotective properties of phytochemicals against paraquat-induced oxidative stress and neurotoxicity in Drosophila melanogaster. Pesticide Biochem Physiol. 2012, 104: 118-125. 10.1016/j.pestbp.2012.07.006.CrossRef
31.
Mahoney MB, Singh CM, Diggins LT, Keefe D, Lund E, O’Neil P, Sigel E, Symonds J, Villaluz A, Ahlijanian MK, Palfreyman MG: Compound screening in a Drosophila melanogaster Alzheimer’s disease model using a behavioral readout. Alzheimers Dement. 2009, 5: e11-e12.CrossRef
32.
Bahadorani S, Bahadorani P, Phillips JP, Hilliker AJ: The effects of vitamin supplementation on Drosophila life span under normoxia and under oxidative stress. J Gerontol A Biol Sci Med Sci. 2008, 63: 35-42. 10.1093/gerona/63.1.35.CrossRefPubMed
33.
Min KJ, Tatar M: Drosophila diet restriction in practice: do flies consume fewer nutrients?. Mech Ageing Dev. 2006, 2006 (127): 93-96.CrossRef
34.
Jayaprakasha GK, Rao LJM, Sakariah KK: Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. J Agric Food Chem. 2002, 50: 3668-3672. 10.1021/jf025506a.CrossRefPubMed
35.
Carvalho Gil B, Kapahi P, Benzer S: Compensatory ingestion upon dietary restriction in Drosophila melanogaster. Nat Methods. 2005, 2: 813-815. 10.1038/nmeth798.CrossRefPubMedPubMedCentral
36.
Choi YH, Yon GH, Hong KS, Yoo DS, Choi CW, Park WK, Kong JY, Kim YS, Ryu SY: In vitro BACE-1 inhibitory phenolic components from the seeds of Psoralea corylifolia. Planta Med. 2008, 74: 1405-1408. 10.1055/s-2008-1081301.CrossRefPubMed
37.
Choi YH, Yoo MY, Choi CW, Cha MR, Yon GH, Kwon DY, Kim YS, Park WK, Ryu SY: A new specific BACE-1 inhibitor from the stembark extract of Vitis vinifera. Planta Med. 2009, 75: 537-540. 10.1055/s-0029-1185311.CrossRefPubMed
38.
Marumoto S, Miyazawa M: beta-secretase inhibitory effects of furanocoumarins from the root of Angelica dahurica. Phytother Res. 2010, 24: 510-513.PubMed
39.
Sasaki H, Miki K, Kinoshita K, Koyama K, Juliawaty LD, Achmad SA, Hakim EH, Kaneda M, Takahashi K: β-Secretase (BACE-1) inhibitory effect of biflavonoids. Bioorg Med Chem Lett. 2010, 20: 4558-4560. 10.1016/j.bmcl.2010.06.021.CrossRefPubMed
40.
Choi CW, Choi YH, Cha MR, Kim YS, Yon GH, Hong KS, Park WK, Kim YH, Ryu SY: In vitro BACE1 inhibitory activity of resveratrol oligomers from the seed extract of Paeonia lactiflora. Planta Med. 2011, 77: 374-637. 10.1055/s-0030-1250370.CrossRefPubMed
41.
John V, Beck JP, Bienkowski MJ, Sinha S, Heinrikson RL: Human β-secretase (BACE) and BACE inhibitors. J Med Chem. 2003, 46: 4625-4630. 10.1021/jm030247h.CrossRefPubMed
42.
Liu H, Li Z, Qiu D, Gu Q, Lei Q, Mao L: The inhibitory effects of different curcuminoids on β-amyloid protein, β-amyloid precursor protein and β-site amyloid precursor protein cleaving enzyme 1 in swap HEK293 cells. Neurosci Lett. 2010, 485: 83-88. 10.1016/j.neulet.2010.08.035.CrossRefPubMed
43.
Ji H, Zhang H: Multipotent natural agents to combat Alzheimer’s disease. Functional spectrum and structural features. Acta Pharmacol Sin. 2008, 29: 143-151. 10.1111/j.1745-7254.2008.00752.x.CrossRefPubMed
44.
Itokawa H, Shi Q, Akiyama T, Morris-Natschke SL, Lee KH: Recent advances in the investigation of curcuminoids. Chin Med. 2008, 3: 11-10.1186/1749-8546-3-11. doi: 10.1186/1749-8546-3-11CrossRefPubMedPubMedCentral
Metadata
Title
Effects of curcuminoids identified in rhizomes of Curcuma longa on BACE-1 inhibitory and behavioral activity and lifespan of Alzheimer’s disease Drosophila models
Authors
Xue Wang
Jun-Ran Kim
Seong-Baek Lee
Young-Joon Kim
Moon Young Jung
Hyung-Wook Kwon
Young-Joon Ahn
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2014
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-14-88

Other articles of this Issue 1/2014

BMC Complementary Medicine and Therapies 1/2014 Go to the issue

Research article

Perilla Extract improves gastrointestinal discomfort in a randomized placebo controlled double blind human pilot study

Research article

Radioprotective effect of the Barbados Cherry (Malpighia glabra L.) against radiopharmaceutical Iodine-131 in Wistar rats in vivo

Research article

The ocular hypotensive effect of saffron extract in primary open angle glaucoma: a pilot study

Research article

Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease

Research article

Chemical composition, antimicrobial and antibiofilm activity of the essential oil and methanol extract of the Mediterranean cypress (Cupressus sempervirens L.)

Research article

NK cells mediate the cumulative analgesic effect of electroacupuncture in a rat model of neuropathic pain